Algernon Pharmaceuticals Finding New Uses for Safe, Older Drugs
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, sat down with Proactive‘s Steve Darling at the 12th annual LD Micro Conference in Bel Air, California. The Vancouver, British Columbia-based company, is advancing its lead compounds for non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, […]
Molekule Air Mini Home Air Purifier Will Debut for $400
Air filters haven’t been known for transformative technology. But UF startup Molekule, a leading innovator in clean air purification, is an ambitious company that is unveiling the $400 Molekule Air Mini as an air purifier for your home that could make a big difference for people with allergies. Molekule Air Mini uses the company’s patented […]
Karen Zaderej, Chairman, CEO, and President of Axogen, Interviewed in Small-Cap Institute Podcast
Small-Cap Institute host Amanda Gerut interviews Karen Zaderej, chairman, CEO, and president of UF startup and UF Innovate | Sid Martin Biotech graduate company Axogen, a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves. Karen has been a part of Axogen since May 2006, serving as Vice President of Marketing and […]
Nematodes Successfully Launched Into Space for First-Ever Agricultural Bio-Control Experiment on ISS
UF startup Pheronym, a bio-ag-tech pest control company, announced that its first-ever agricultural bio-control experiment featuring beneficial nematodes is on its way to the International Space Station (ISS) U.S. National Laboratory after a successful launch at the Kennedy Space Center. The nematodes were on a SpaceX Falcon9 rocket, launching the 21st Dragon spacecraft mission on […]
New Digital Therapy Platform Introduced to Enhance Mental Health Services for Students
Mental health services for the University of Lethbridge students are receiving an online boost with the introduction of TAO Connect, a University of Florida digital platform startup designed to make behavioral health therapy more accessible and effective. Through TAO (therapy assistance online) Connect, students in Alberta, Canada, now have access to an app providing behavioral […]
Smartisan Technology Becomes Global Partner of Anti-Bacteria Technology Provider Sharklet
Niche smartphone brand Smartisan Technology, a Chinese multinational technology company headquartered in Beijing and Chengdu, announced global partnership with UF startup and UF Innovate | Sid Martin Biotech alum Sharklet Technologies Inc. It had been revealed that the partnership had nothing to do with smartphones, but was related to the medicare industry. “New technology, no matter […]
VetiOx Named Top Product of 2019 by Pet Business Magazine
University of Florida startup, UF Innovate | Sid Martin Biotech alum, and UF Innovate | The Hub resident company ReliOx Corporation, a specialty chemical technology company that specializes in introducing disruptive chemistries into critical industrial and general use applications, was featured in Pet Business Magazine with its product VetiOx as one of the top products […]
Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), announced the completion of enrollment in its ongoing double-blind, randomized, placebo-controlled Phase 2 trial of its lead product candidate, AG013, an easy-to-use oral rinsing […]
Algernon Pharmaceuticals Provides Update on Its Planned Phase II Clinical Trial
UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, provided an update to the market on its planned phase II clinical trial and its additional plans for 2020. The company is focused on developing repurposed therapeutic drugs. Drug repurposing (also known as re-profiling, re-tasking or therapeutic switching) […]
DNAtrix Presents Positive Results From Study at the 2019 SNO Annual Meeting
UF startup DNAtrix, a leader in the development of oncolytic viruses for cancer therapy, presented updated safety and efficacy data from the fully-enrolled Phase 2 CAPTIVE / KEYNOTE-192 study of DNX-2401 (tasadenoturev), DNAtrix’s oncolytic adenovirus, followed by pembrolizumab for patients with recurrent glioblastoma. The data demonstrate that the therapy elicits durable clinical activity and has a […]